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Insertion of a functional splicing cassette into a construct containing the HIV-1 poly(A) site followed by the adenovirus
L3 poly(A) site results in both specific stimulation of 3* end processing at the HIV-1 site and an increase in the steady-
state levels of RNA processed at both sites. To further evaluate this influence of splicing on processing of the HIV-1 poly(A)
site, defined mutations which alter or abolish splicing of the intron were made and analyzed for their effects on polyadenyla-
tion and steady-state levels of RNA. The data show that a point mutation at the 3* splice site caused activation of a cryptic
splice acceptor that is as efficient as the wild-type acceptor. Substitution of this mutant intron for the wild-type intron
resulted in stimulation of the HIV-1 poly(A) site to levels equivalent to those caused by the wild-type intron. This mutant
did not, however, have as great an effect on steady-state RNA levels as the wild-type intron. A second construct containing
a mutated branch point and polypyrimidine tract resulted in abolishment of splicing and a decrease in both poly(A) site use
and steady-state levels of RNA. These data demonstrate that the enhanced use of the HIV-1 poly(A) site is a direct result
of the splicing reaction, and not merely due to the sequences that were inserted. The effect that poly(A) site strength has
on splicing was also addressed. Using activation of the cryptic splice acceptor to indicate changes in splicing efficiency
resulting from alterations in poly(A) site strength, it was determined that poly(A) site strength does have an effect on the
efficiency of the splicing reaction. q 1996 Academic Press, Inc.
INTRODUCTION 1987; Carswell and Alwine, 1989; DeZazzo and Imperiale,
1989; Russnak and Ganem, 1990; Sanfacon et al., 1991;
The biogenesis of mRNA in higher eukaryotes involves DeZazzo et al., 1991; Valsamakis et al., 1991; Brown et
substantial processing of primary transcripts to produce al., 1991). Several multicomponent protein factors are
mature mRNA molecules. Two of these processing steps essential for the cleavage and polyadenylation reaction
are polyadenylation, which forms the 3* end, and splicing, and include cleavage/polyadenylation specificity factor
which removes intervening sequences. Much is known (CPSF), cleavage stimulatory factor (CstF), poly(A) poly-
about the cis-acting sequences and trans-acting factors merase (PAP), and cleavage factors I and II (CFI and
that are essential for these reactions. Polyadenylation CFII).
is the site-specific endonucleolytic cleavage of the pre- Pre-mRNA splicing is the accurate removal of introns
mRNA followed by the template-independent addition of and joining of exons. Similar to polyadenylation, splicing
approximately 200 adenosine residues which make up also involves specific sequences and protein factors (for
the poly(A) tail (for reviews, see Manley, 1988; Wahle reviews, see Green, 1991; Moore et al., 1993). The con-
and Keller, 1992; Wahle, 1995). The minimal sequences sensus sequences necessary for splicing are a GU dinu-
required for polyadenylation are the highly conserved cleotide at the 5* splice site and an AG dinucleotide at
hexanucleotide sequence, AAUAAA, that lies 10–30 nt the 3* splice site, along with the branch point residue
upstream of the poly(A) addition site and a G/U- or U- and polypyrimidine tract located just upstream of the 3*
rich sequence found within 50 nt downstream of the splice site. The length and pyrimidine content of the
cleavage site. Additional accessory sequences that can polypyrimidine tract have been shown to be key determi-
regulate the efficiency of poly(A) site use have also been nants in the splicing strength of an intron (Reed, 1989;
identified both upstream and downstream of the core Roscigno et al., 1993). Careful analysis of the sequences
signals in several viral systems (Dougherty and Temin, surrounding splice sites has revealed that other se-
quences located in both introns and exons can also influ-
ence the efficiency of splicing (Nesic and Maquat, 1994;1 To whom correspondence and reprint requests should be ad-
Lavigueur et al., 1993; Humphrey et al., 1995; Tian anddressed at University of Michigan Medical School, 6714 Medical Sci-
Maniatis, 1993, 1994; Watakabe et al., 1993). The splicingence II, Ann Arbor, MI 48109-0620. Fax: (313) 764-3562. E-mail: imperi-
al@umich.edu. reaction is catalyzed by a large multicomponent complex
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called the spliceosome, which includes small nuclear sions. In vitro studies suggested that polyadenylation can
positively influence splicing in that, when 3* end pro-ribonucleoprotein particles (snRNPs) and additional es-
sential proteins. Much of our understanding of the mech- cessing signals were mutated, splicing of the proximal
upstream intron was depressed without affecting splic-anisms of polyadenylation and splicing has come from
cell-free systems in which the two events are studied ing of more distant upstream introns (Niwa and Berget,
1991). The conflicting report looked at the effect of poly-separately; a poly(A) site can be cleaved in the absence
of splicing and a pre-mRNA which contains an intron but adenylation on splicing in the human triosephosphate
isomerase gene in intact cells and indicated that thelacks a poly(A) site can still be spliced. Additionally, the
factors which have been shown to be essential for poly- efficiency of the poly(A) site had no effect on splicing of
the two nearest introns (Nesic et al., 1995). Therefore, thisadenylation and splicing have not shown any overlap. In
spite of this, the observation that there are no examples debate regarding the reciprocal effects of the processing
events is not closed.of mRNAs that are spliced without also being polyadenyl-
ated suggests that the two processing steps may be Viruses, because of their ability to usurp the cell’s ma-
chinery for their own gene expression and regulation,linked in the cell.
The idea that splicing and polyadenylation may be can provide powerful systems for exploring the various
echelons of control that the cell has developed. Previouscoupled reactions is consistent with the exon definition
theory of splice site recognition (Robberson et al., 1990), studies from our laboratory which addressed the relative
roles of promoter proximity and upstream sequences inwhich states that a 3* terminal exon is identified by splic-
ing factors binding at its 5* end and by polyadenylation HIV-1 mRNA 3* end formation demonstrated that a func-
tional splicing cassette inserted between the promoterfactors binding at its 3* end. Indeed, there have been
several reports to date that demonstrate coupling of the and the poly(A) site could specifically increase HIV-1
poly(A) site use as well as the total levels of processedsplicing and polyadenylation reactions. Berget and col-
leagues have shown in vitro that polyadenylation can be transcripts in the steady-state pool (DeZazzo et al., 1992).
In these studies, we deleted the 5* or the 3* half ofstimulated by an intron located upstream in the precursor
RNA (Niwa et al., 1990). More recently, they have shown the intron to determine if these effects were due to the
sequences surrounding either of the splice sites individu-that polyadenylation can be activated in vitro by a down-
stream intron enhancer containing a polypyrimidine tract ally. Analysis of the processing of transcripts produced
by these constructs showed that the 5* splice site aloneand a pseudo-5* splice site sequence (Lou et al., 1996).
This enhancer was shown to bind to several splicing had no effect on steady-state RNA levels. The 3* splice
site alone, however, caused an increase in the steady-factors and the binding of these factors was required for
activation of 3* end cleavage, providing further evidence state levels of RNA and specifically enhanced the use of
the HIV-1 poly(A) site. Further analysis showed that, eventhat splicing factors can influence polyadenylation
in vitro. though the 5* splice donor sequences had been deleted,
a significant number of these transcripts were beingSeveral transfection systems have also demonstrated
that functional introns can have a profound effect on spliced to a cryptic 5* splice site and the increase in the
steady-state level of polyadenylated RNA correlated withpolyadenylation and subsequent gene expression (Chiou
et al., 1991; Miller and Stoltzfus, 1992; Huang and Gor- the observed level of cryptic splicing. The experiments
presented in this report were designed to investigateman, 1990; Villarreal and White, 1983; Nesic and Maquat,
1994; Nesic et al., 1993; DeZazzo et al., 1992; Liu and further the apparent coupling of splicing and polyadenyl-
ation with respect to the strength of the HIV-1 poly(A)Mertz, 1993). This positive influence of splicing on poly-
adenylation may be due, at least in part, to the involve- site. We have made defined mutations in the intron that
impair or abolish splicing and evaluated the effect thatment of the U1 snRNP-A protein (U1A), which has been
shown to bind to the upstream efficiency element in the these mutations have on both processing of the HIV-1
poly(A) site and steady-state RNA levels. Our resultssimian virus 40 late poly(A) site (Lutz and Alwine, 1994;
Wassarman and Steitz, 1993). The U1A protein can inter- show that when mutations are made in the intron that
render it nonfunctional, there is no enhancement of 3*act with both the U1 snRNA and the pre-mRNA simultane-
ously via its two RNA recognition motifs (Lutz and Alwine, end processing nor any stimulation of steady-state RNA
levels, thus providing direct evidence of a positive role1994), thereby potentially serving as a bridging molecule
for communication between the splicing and polyadenyl- for splicing on polyadenylation. We have also examined
the effects polyadenylation has on the splicing efficiencyation machineries. Indeed, U1A has recently been shown
to contact the 160-kDa subunit of CPSF directly (Lutz et of our intron-containing constructs. Using two versions
of the HIV-1 poly(A) site, either containing long terminalal., 1996).
With respect to the reciprocal influence polyadenyla- repeat (LTR) U3 sequences, which make the site very
efficient, or lacking these sequences, we find that poly(A)tion may have on splicing, we are aware of only two
reports, the data of which point to conflicting conclu- site strength does influence the splicing reaction. These
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results are consistent with a model in which the polyade- (Gibco-BRL) supplemented with 10% fetal bovine serum
(Hyclone Laboratories, Inc.) and 0.2 mM L-glutaminenylation and splicing machineries positively influence
each other in order to define and process the terminal (Gibco-BRL). Monolayer cultures at approximately 40%
confluence were transfected with 10 mg assay plasmidexon of a pre-mRNA molecule. Within the compact ge-
nome of HIV-1, there are several alternative splice sites and 5 mg control plasmid by the CaPO4 precipitation
method. The DNA was removed 24 hr after transfection,which are used to produce at least seven different tran-
scripts, and this level of complexity suggests a sophisti- and RNA was purified 24 hr later by acid guanidinium
isothiocyanate–phenol–chloroform extraction (Chomc-cated method of regulating gene expression. The experi-
ments in this report explore the possible interactions zynski and Sacchi, 1987). The RNA was quantitated by
A260 spectroscopy and agarose gel electrophoresis. Thebetween polyadenylation and splicing that accomplish
this intricate regulation of gene expression. poly(A)/ fraction was isolated from 50 mg total RNA using
oligo(dT)-cellulose chromatography (Boehringer Mann-
heim Biochemicals). The poly (A)0 RNA fraction was ob-EXPERIMENTAL PROCEDURES
tained by depleting total RNA of poly(A)/ RNA via sequen-
Plasmid constructions tial oligo(dT) columns until we could no longer detect
the poly(A)/ transfection control RNA by S1 nucleaseThe plasmids used in this study are derivatives of
protection.pGEM 3Zf- (Promega) containing a 435-bp adenovirus
major late promoter (MLP) fragment followed by tandem S1 nuclease mapping and quantitation
(Fig. 1A) or single (Fig. 3A) poly(A) sites. Tandem poly(A)
To determine the steady-state levels of transcriptssite constructs contain a 400-bp fragment of the HIV-1
polyadenylated at the HIV-1 or L3 poly(A) sites, poly(A)/LTR followed directly by the adenovirus L3 poly(A) site
RNA fractions were coprecipitated with 30 ng 3* end-and have been described previously (DeZazzo et al.,
labeled probe (5 1 105 to 1 1 106 cpm) and 25 mg yeast1992). Single poly(A) site constructs were made which
tRNA. The probe was made by filling in the ends of ancontain the HIV-1 poly(A) site fragment with or without
816-bp XbaI fragment that spans both poly(A) sites withLTR U3 sequences. The construct lacking U3 (DU3) has
[a-32P]dCTP (Amersham) using Klenow enzyme (BRL).an equivalent size fragment from the HIV-1 envelope
The levels of spliced product from constructs containinggene which has no effect on polyadenylation (DeZazzo
splicing signals were determined using 5* end-labeledet al., 1991). The splicing cassette used for these con-
probes. These probes were made by linearizing plasmidstructs is a 120-nucleotide intron derived from adenovi-
DNA (pIVSU3-L3, p3*MU3-L3, or pPTMU3-L3) with BglII,rus 2 sequences (Niwa et al., 1990) and in this paper is
which cuts in the HIV-1 R sequence, labeling the 5* endreferred to as ‘‘wild type.’’ To make the construct con-
with [g-32P]dATP using T4 polynucleotide kinase, andtaining a 3* splice site mutation, the intron from pMXSVL
finally digesting upstream of the transcription start site3* (kindly provided by Sue Berget (Niwa et al., 1990)) was
with XhoI for constructs containing U3 sequences, oramplified by PCR using exon-specific primers. This intron
with StuI for DU3 constructs. In each case, a labeledhas a single base change (G r A) at the consensus
fragment of 680 nucleotides is produced which spanssplice acceptor dinucleotide (Fig. 1A). A second splicing
the promoter and splice signals. These probes detectmutant was made by PCR site-directed mutagenesis to
both spliced and full-length assay transcripts as wellinactivate the branch point and polypyrimidine tract. Ex-
as the control RNA. The poly(A)/ RNA fractions wereact base changes in the mutant are indicated in Fig. 1A.
hybridized overnight at 527 for the 3* end-labeled probe,The mutant introns were then inserted between the MLP
or 577 for the 5* end-labeled probe. Hybridized samplessequences and the poly(A) sites via BamHI linkages. Mu-
were then treated with S1 nuclease (BRL) at 257 for 2 hrtations were confirmed by dideoxynucleotide sequenc-
under conditions that have been previously describeding. Other plasmids used in this study include pU3F-L3,
(DeZazzo et al., 1992). The protected fragments werepU3C-L3, p3*U3-L3, and pDBSVF and have been de-
resolved on a 6% polyacrylamide–8 M urea gel and visu-scribed previously (DeZazzo et al., 1992). pDBSVF con-
alized by autoradiography. The gels were also exposedtains the MLP followed by 160 nucleotides of U3-R se-
to a PhosphorImager screen for quantitative analysis us-quences from HIV-1 and the SV40 early poly(A) site and is
ing ImageQuant software (Molecular Dynamics). Theseused to control for differences in transfection efficiency.
values were used to determine the total levels of polyade-Plasmids were propagated in Escherichia coli DH5a and
nylated RNA or the percentage of spliced product forpurified using the Qiagen plasmid purification protocol.
each construct.
Transient transfections and RNA preparation RESULTS
Our previous work which addressed the relative rolesThe human 293 cell line (Graham et al., 1977) was
maintained in Dulbecco’s modified Eagle’s medium of promoter proximity and upstream sequences on pro-
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FIG. 1. Diagram of transfection constructs and predicted S1 analysis products. (A) Diagram of constructs. Each construct contains two poly(A)
sites: the HIV-1 poly(A) site including stimulatory U3 sequences (open boxes) and the adenovirus L3 poly(A) site (hatched boxes). Cleavage sites
are indicated by the downward arrows. Rightward arrow denotes the transcription start site of the adenovirus major late promoter (MLP). Constructs
containing wild-type and mutant splicing cassettes inserted into pU3C-L3 are also diagrammed. The splicing cassette is designated by the large
open boxes connected by the V-shaped line. In p3*U3-L3, the splice donor and 5* half of the intron have been deleted. The large asterisk in p3*MU3-
L3 represents the splice acceptor (SA) point mutation AG r AA and the upward arrowhead marks the cryptic SA that is activated (see text). The
specific mutations made at the branch point (bp) and within the polypyrimidine tract (ppt) to create pPTMU3-L3 are indicated. Transfection control
plasmid pDBSVF contains HIV-1 U3 sequences followed by the SV40 early poly(A) site (SVE). Restriction sites: O, XhoI; X, XbaI; G, BglII. (B) S1
probes and predicted fragments to detect polyadenylation (3* end-labeled at the XbaI site) or splicing (5* end-labeled at the BglII site). Probe and
protected fragment sizes from the various RNA species are indicated. A simplified diagram of the constructs is provided for reference.
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TABLE 1cessing of the HIV-1 poly(A) site demonstrated that when
a functional splicing cassette was inserted into con- Level of 3* End Processing
structs which contained the complete HIV-1 poly(A) site
HIV / L3/(i.e., with LTR U3 sequences), both the strength of this
Construct HIV/L3a controlbsite relative to a downstream site and the steady-state
level of processed RNA were enhanced (DeZazzo et al.,
pU3F-L3 34 { 4 1.5 { 0.1
1992). The positive influence of splicing on polyadenyla- pIVSU3-L3 39 { 7 1.3 { 0.3
tion was supported by experiments in which a splicing p3*MU3-L3 30 { 3 0.3 { 0.1
p3*U3-L3 15 { 5 0.20 { 0.03cassette containing only the 3* half of the intron also
pU3C-L3 5 { 1 0.05 { 0stimulated polyadenylation, albeit at an intermediate
pPTMU3-L3 1.8 { 0.2 0.03 { 0.01level. This degree of stimulation correlated with an inter-
mediate level of splicing compared to that of the wild- Note. Results are averages of 2–4 experiments { standard devia-
type intron and was most likely due to the lack of an tions.
a The ratio of RNA processed at the HIV poly(A) site to that processedauthentic splice donor and consequent use of a cryptic
at the L3 poly(A) site.donor site(s). Based on these data, we hypothesized that
b The total amount of RNA processed at both sites, normalized tothe increases in poly(A) site use and in steady-state lev-
control.
els of RNA were a direct result of the splicing reaction
and not simply due to sequences that had been inserted.
tional construct, pPTMU3-L3, was made by PCR site-di-
rected mutagenesis. In this construct the branch pointDirect effects of splicing on polyadenylation
residue is changed from A to G and extensive purine
substitutions are present in the polypyrimidine tract.Others have shown that gene expression can be posi-
tively affected by the insertion of a functional intron into The plasmids were transfected side by side into the
human embryonic kidney cell line 293. 293 cells constitu-the expression construct (Buchman and Berg, 1988; Ryu
and Mertz, 1989) and in some cases this enhancement tively express adenovirus E1A proteins, which transacti-
vate the adenovirus MLP contained in the plasmids. Eachis due to increased polyadenylation (Chiou et al., 1991;
Huang and Gorman, 1990). We wished to determine if plasmid was cotransfected with pDBSVF as a control
for transfection efficiency. The RNA generated from thisthe stimulation seen in our system was a direct result of
splicing, or was instead simply due to some other form control plasmid is used to calculate the relative levels of
spliced or polyadenylated RNA, enabling us to compareof enhancement by the inserted sequences. To this end,
defined mutations were made in the splicing cassette the processing events on various transcripts that are
assayed with different probes. We first examined 3* endthat either impaired or abolished splicing. The transcripts
from these constructs were evaluated with respect to the formation by S1 nuclease analysis of poly(A)/ RNA using
a 3* end-labeled XbaI fragment that spanned both poly(A)relative use of the HIV-1 poly(A) site, steady-state levels
of RNA, and splicing efficiency. If the splicing reaction sites (Fig. 2A and Table 1). Compared to pU3C-L3, the
relative use of the HIV-1 poly(A) site is increased in pre-can indeed stimulate polyadenylation, alteration of the
authentic splicing signals to suboptimal or nonfunctional mRNAs containing the wild-type or the 3* mutant intron
(Fig. 2A, compare lanes 3 and 4 to lane 5). Additionally,sequences should cause a decrease in polyadenylated
transcripts in the steady-state pool. The constructs used steady-state levels of the processed transcripts are in-
creased, although to a lesser degree for p3*MU3-L3. Infor this study are diagrammed in Fig. 1. Each construct
contains the adenovirus MLP followed by tandem poly(A) contrast, however, there is no stimulation of processing
and actually a reduction in steady-state RNA levels whensites, HIV-1 and adenovirus L3. The L3 poly(A) site serves
as a default site for 3* end processing of transcripts that the branch point and polypyrimidine tract are mutated
(lane 6). Thus, it appears that specific mutations in criticalare not processed at the HIV-1 site. The constructs used
in our original study are pU3F-L3, pU3C-L3, and pIVSU3- splicing sequences adversely affect 3* end processing.
To evaluate splicing in these transcripts, poly(A)/ RNAL3. pU3F-L3 has the HIV-1 poly(A) site 1207 nt from the
cap site. In pU3C-L3 the HIV-1 poly(A) site is located was hybridized to 5* end-labeled probes and treated with
S1 nuclease (Fig. 2B). These probes include all introncloser to the cap site (270 nt), and pIVSU3-L3 is pU3C-
L3 with a 120-nt intron inserted between the MLP and sequences and therefore can detect spliced and un-
spliced products regardless of which poly(A) site is used.the HIV-1 sequences. To make p3*MU3-L3, we amplified
the intron from pMXSVL 3* by PCR. This intron is identical A probe made from pIVSU3-L3 was used for analysis of
the RNA from the transfections with pIVSU3-L3 andto that found in pIVSU3-L3 except it contains a point
mutation at the splice acceptor site to change the con- p3*U3-L3. p3*U3-L3 contains only the 3* half of the intron,
resulting in a moderate level of stimulation (Table 1) thatsensus AG to AA. In vitro, this mutation has been shown
to inhibit splicing completely (Niwa et al., 1990). An addi- correlates with the intermediate level of splicing shown
AID VY 8190 / 6a20$$$$81 09-16-96 15:30:32 viras AP: Virology
503RECIPROCAL EFFECTS OF SPLICING AND POLYADENYLATION IN HIV-1
FIG. 2. S1 analysis of RNA processing events in the presence of wild-type and mutant splicing cassettes. (A) S1 analysis of 3* end formation.
S1 products from analysis of the poly(A)/ fraction of 50 mg RNA are shown. Transcripts polyadenylated at the HIV-1 site protect a 242-nt probe
fragment while transcripts polyadenylated at the L3 site result in a 657-nt fragment. The full-length probe (P) and the fragment protected by the
transfection control RNA (C) are indicated. Lane 1, molecular weight markers, lanes 2–6, S1 analysis of the indicated transfection RNAs, lane 7,
S1 sample containing only probe. (B) S1 analysis of splicing levels in poly(A)/ fraction. Unspliced transcripts protect a fragment of 420-nt (arrowhead)
while spliced transcripts protect 210 nt when the wild-type SA is used (filled circle), or 198 nt when the cryptic SA is used (open circle). The
unspliced fragment size for p3*U3-L3 is shorter, 330 nt, because of deletion of the 5* half of the intron.
in Fig. 2B, lane 3. To assay the splicing levels from polypyrimidine tract mutations. Again, the level of poly(A)
site stimulation shown in Fig. 2A correlates with thesep3*MU3-L3 and pPTMU3-L3, probes were made from the
corresponding plasmids. Note that the spliced transcript splicing activities, and we therefore conclude that the
enhancement of the HIV-1 poly(A) site and of steady-from p3*MU3-L3 protects a shorter probe fragment than
the wild-type spliced transcript, indicating that a cryptic state levels of RNA occurs as a result of splicing and is
not due to nonspecific effects of sequences within thesplice acceptor has been activated. Probe fragments that
migrate slower than the unspliced bands are background intron cassette.
bands as judged by their presence in samples lacking
RNA (data not shown). The radioactivity in each band was Influences of poly(A) site strength on splicing
quantitated and used to determine the relative splicing
efficiencies. In p3*MU3-L3, splicing to the cryptic ac- Having shown that splicing stimulates both 3* end pro-
cessing efficiency and steady-state RNA levels, we wereceptor was as efficient as that to the wild-type acceptor
in the wild-type construct (98.4 vs 99.6%). In contrast, next interested in determining if the opposite was true,
i.e., whether poly(A) site strength has any influence onsplicing was completely inhibited by the branch point –
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splicing in our system. To measure effects on splicing strates that in the steady-state pool, there are no spliced
transcripts which have escaped polyadenylation. None-efficiency due to changes in the strength of the poly(A)
site, we used activation of the cryptic splice acceptor theless, we do find polyadenylated transcripts which re-
main unspliced from this construct while nearly all of thebecause we felt it would be very sensitive to perturba-
tions of any potential interactions between the pro- polyadenylated transcripts with the wild-type intron are
spliced. Together, these experiments show that substitu-cessing machineries. For these studies, we constructed
plasmids that contain either the wild-type or the 3* mutant tion with the weak poly(A) site results in lower levels of
spliced steady-state RNA. Therefore, we conclude thatintron followed by the HIV-1 poly(A) site (Fig. 3A). The
strength of the poly(A) sites in these constructs was cate- the strength of the poly(A) site does have an effect on
splicing efficiency.gorized as either ‘‘strong’’ or ‘‘weak’’ based on the pres-
ence or absence of the stimulatory U3 sequences, re-
spectively (DeZazzo et al., 1991, 1992). These constructs DISCUSSION
do not contain the very efficient L3 poly(A) site in order
to avoid dominant effects that it may have on splicing The data presented in this report demonstrate the stim-
ulatory effect of an intron on polyadenylation and con-when the weak HIV-1 poly(A) site is present. Within each
pair of plasmids, the degree of splicing that occurs at versely, the positive role of a poly(A) site on splicing of
the terminal intron. In our previous work, we noted athe cryptic splice acceptor of the 3* mutant intron indi-
cates the effect that poly(A) site strength has on splicing: marked stimulation of the HIV-1 poly(A) site, even in com-
petition with a strong L3 poly(A) site downstream, whenif poly(A) site strength can influence splicing, the strong
poly(A) site should drive the splicing reaction to take an intron was placed between the promoter and the po-
ly(A) site (DeZazzo et al., 1992). This enhancement wasplace at the cryptic splice acceptor in the mutant intron,
whereas the weak poly(A) site should result in reduced dependent on the presence of U3 sequences, as stimula-
tion of the relative use of the HIV-1 site was not seen insplicing at the cryptic site.
S1 analysis of the RNA with a 3* end-labeled probe to constructs that lacked U3 sequences. Additionally, we
observed an increase in steady-state levels of processeddetect polyadenylation demonstrates that, although both
the strong and weak HIV-1 poly(A) sites are functional, RNA that was independent of the strength of the poly(A)
site. In the current study, our objective was to determinethe DU3 constructs produce much less steady-state RNA
(Fig. 3B). A 5* end-labeled probe used to analyze splicing if the stimulation caused by the intron was a direct result
of the splicing reaction or due to some other enhance-shows that transcripts containing the strong poly(A) site
with either intron were spliced very efficiently (Fig. 3C, ment of polyadenylation by the sequences contained
within the intron. To inhibit splicing through minimallanes 1 and 2, Table 2). Additionally, the cryptic splice
acceptor in the 3* mutant intron is activated in the pres- changes of the intron sequence, we chose to mutate the
splice acceptor, based on in vitro results that demon-ence of either the strong or the weak HIV-1 poly(A) site
(lanes 2 and 4). Quantitation of the bands revealed, how- strated that such a mutation completely abolishes splic-
ing (Niwa et al., 1990). We found that this mutation didever, that in the weak poly(A) site constructs, 95% of the
poly(A)/ transcripts containing the wild-type intron were not abolish splicing in vivo, but instead led to activation
of a cryptic splice acceptor. Splicing at the cryptic ac-spliced while only70% of the transcripts containing the
3* mutant intron were spliced at the cryptic splice ac- ceptor was as efficient as splicing at the wild-type ac-
ceptor when the strong, U3-containing HIV-1 poly(A) siteceptor (Table 2). This shows that the strength of the po-
ly(A) site does influence splicing in these transcripts. It was used. In addition, it had the same stimulatory effect
on polyadenylation as the wild-type intron. Mutating thewas possible, however, that by examining only poly(A)/
RNA, we might not have detected splicing events that cryptic acceptor led to activation of a second cryptic ac-
ceptor farther downstream, again with equivalent effectsoccurred on poly(A)0 transcripts. To examine whether a
significant number of transcripts from p3*MDU3 were on polyadenylation (data not shown); therefore we de-
cided to mutate the polypyrimidine tract and branch pointbeing spliced but not polyadenylated, we analyzed the
poly(A)0 fraction (Fig. 4). Total RNA was fractionated us- residue to abolish splicing. We found that splicing of this
mutant intron is completely inhibited in vivo and that theing oligo(dT)-cellulose until the poly(A)/ RNA signal, as
measured by the 5* end-labeled probe, was no longer observed stimulation of both polyadenylation and steady-
state RNA levels is also abrogated. We feel it is unlikelydetectable in the eluates by S1 analysis (Fig. 4, lane 2).
The column flow-through fraction was then analyzed us- that we have removed any enhancing or accessory se-
quences directly involved in polyadenylation as a resulting the 5* probe to detect spliced, nonpolyadenylated
transcripts (Fig. 4, lane 3). This analysis shows that no of these changes and therefore, taken together, the data
from the splicing mutants show that it is indeed the splic-spliced transcripts are detectable in the poly(A)0 fraction.
Although it is possible that these transcripts might be ing of the intron which results in stimulation of the HIV-
1 poly(A) site.very unstable and difficult to detect, this assay demon-
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FIG. 3. S1 analysis of polyadenylation and splicing levels in constructs containing weak or strong HIV-1 poly(A) sites. (A) Diagram of plasmids. Single
poly(A) site constructs contain either a weak (DU3) or a strong (U3) HIV-1 poly(A) site following a wild-type or 3* mutant intron. Symbols are as in Fig. 1A.
S denotes StuI. (B) S1 analysis of 3* end formation. Lanes 2–5 show S1 products of the poly(A)/ fraction from 50 mg transfection RNA. Lanes 1 and 6 are
samples containing probe (U3 or DU3, respectively) but no RNA. Full-length probe, HIV-1, and control bands are indicated as in Fig. 2. RT (read through)
indicates where the probe sequence diverges from the RNA sequence. (C) S1 analysis of splicing levels in poly(A)/ fraction. Lanes 1 and 2 are from
constructs containing the strong HIV-1 poly(A) site downstream of the wild-type or the 3* mutant intron, respectively. Similarly, lanes 3 and 4 are from the
constructs bearing the weak HIV-1 poly(A) site following either of the introns. Unspliced and spliced products are indicated for both introns as in Fig. 2B.
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TABLE 2 splicing occurs at a lower rate when the poly(A) site is
weak. We therefore conclude that poly(A) site strengthSplicing Efficiencies
does have an impact on the splicing of the terminal intron
Construct % Spliceda in vivo. What effect it may have on splicing of other introns
farther upstream has not been determined in these ex-
pIVSU3 99.7 { 0.1 periments as our constructs contain only one intron. In
p3*MU3 94 { 2
vitro studies have demonstrated that mutation of thepIVSDU3 95 { 2
AAUAAA sequence to inhibit polyadenylation results inp3*MDU3 71 { 7
a reduction of splicing of the proximal intron but not the
a Percentage spliced indicates (amount spliced/total poly(A)/ RNA) more distal introns, supporting the idea that polyadenyla-
1 100. tion is coupled only to splicing of the terminal intron
(Niwa and Berget, 1991). Although our results are in
agreement with these in vitro studies, they conflict withInsertion of a functional intron also increased the
steady-state level of poly(A)/ RNA. It is now generally a report in which no change in splicing levels was de-
accepted that to achieve high levels of gene expression,
one must include an intron in the expression construct.
The mechanism of how the intron results in higher ex-
pression is not clear, but is likely to involve increased
nuclear RNA stability, polyadenylation, and/or nucleocy-
toplasmic transport of the processed mRNA. In a study
addressing this question directly, several steps in mRNA
biogenesis were analyzed for two constructs that differed
only in the presence or absence of a complete intron
(Huang and Gorman, 1990). All parameters tested were
equal for the two constructs with the exception of levels
of polyadenylated, nuclear RNA, suggesting that splicing
may be coupled to the polyadenylation/transport path-
way. Other laboratories have also described dramatic
differences in expression levels of genes that contain
an intron compared to those that lack the intervening
sequence (Buchman and Berg, 1988; Ryu and Mertz,
1989; Chiou et al., 1991; Huang and Gorman, 1990). In
these reports, splicing was crippled as a result of gross
deletions of the intron, and reductions in steady-state
RNA levels were observed. The experiments in the pres-
ent study use defined mutations to abolish splicing with-
out making such drastic alterations to the intron. When
splicing was inhibited, the stimulatory effect on the po-
ly(A) site was lost and therefore, our results are consis-
tent with the exon definition model in which splicing and
polyadenylation are coupled processing events in intact
cells.
An additional objective of this paper was to determine
if the poly(A) site was having any effect on the splicing
reaction. We reasoned that because splicing is able to
play such a dramatic role in the overall biogenesis of
mRNA through its effect on 3* end processing, it is possi-
ble that the stimulation might be bidirectional. In our
experiments, we used the activation of a cryptic splice
acceptor as a sensitive readout for any such stimulation.
FIG. 4. S1 analysis of poly(A)0 fraction. Total transfection RNA fromBy deleting the U3 sequences from the HIV-1 poly(A) site,
p3*MDU3 was oligo(dT) selected until the transfection control signalwe have converted it to a very weak poly(A) site (DeZazzo
was no longer detectable in the column eluates with the 5* end-labeled
et al., 1991; Valsamakis et al., 1991; Brown et al., 1991). probe (lane 2). Column flow-through was then analyzed as poly(A)0
Analysis of the splicing efficiencies of these constructs with the same probe (lane 3). Unspliced and spliced products are
indicated as in Fig. 2B. Lane 1, poly(A)/ fraction, lane 4, no RNA.containing wild-type or mutant introns demonstrated that
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tected in vivo when the efficiency of 3* end formation in et al., 1992). In these experiments, polyadenylation was
inhibited through depressed binding of the polyadenyla-the triosephosphate isomerase pre-mRNA was altered
by deletion or substitution of the poly(A) site (Nesic et tion factor CstF. Perhaps by a similar mechanism, bovine
papillomavirus late gene expression is inhibited by aal., 1995). These differences may be due to (i) a higher
level of sensitivity in our assay which used the cryptic consensus 5* splice site found in the terminal exon (Furth
et al., 1994). This splice site is not used in these tran-splice acceptor, (ii) a reflection of behavioral differences
between viral and cellular processing signals, or (iii) sim- scripts, but its inhibitory effects are dependent on binding
to the U1 snRNP. Based on this information, it is possibleply an indication that transcription units are regulated in
a variety of ways. that the reduction in steady state RNA levels that we
observe for the branch point–polypyrimidine tract mutantAn interesting question is what is the mechanism by
which these two seemingly independent processing is due to the fact that the splice donor is not paired with
a functional splice acceptor. Consequently, interactionsevents can stimulate each other? With respect to steady-
state RNA levels, it is possible that the assembly of the of splicing factors at the 5* splice site may interfere with
terminal exon definition and polyadenylation directly, orspliceosome on the transcript could help stabilize the
pre-mRNA in the nucleus until processed, followed by simply result in nuclear retention of the transcript. These
examples demonstrate the variety of mechanisms bythe efficient export of the mRNA to the cytoplasm. Per-
haps this is how introns can stimulate ‘‘generic’’ gene which sequences and processing factors contribute to
the regulation of gene expression.expression, but in the case of HIV-1, splicing of the intron
in the presence of U3 sequences produces an additive We would argue that in the HIV-1 provirus, these recip-
rocal effects may be important for the regulation of RNAeffect on polyadenylation (DeZazzo et al., 1992). It has
been well documented that U3 sequences are important processing. The 3* splice sites in HIV-1 are suboptimal
sequences, a condition that is important for the balancedfor efficient 3* end formation in HIV-1 (DeZazzo et al.,
1991; Valsamakis et al., 1991; Brown et al., 1991). Recent production of spliced, partially spliced, and unspliced
transcripts required for a productive infection (Dyhr-Mik-studies have shown that these sequences enhance poly-
adenylation by stabilizing the binding of CPSF at the kelsen and Kjems, 1995; O’Reilly et al., 1995). In addition,
terminal sequence redundancy in the provirus results inpoly(A) site (Gilmartin et al., 1995). At the 5* end of the
terminal exon, splicing factors, including U1 snRNP, as- polyadenylation signals at both the 5* and the 3* ends
of the pre-mRNA that require regulation: polyadenylationsemble the spliceosome on the terminal intron. A compo-
nent of the U1 snRNP, the U1A protein, has been shown must occur at the site in the 3* LTR to ensure adequate
gene expression and genome production. As mentionedto also bind to distinct sequences in the upstream effi-
ciency element of SV40 late poly(A) site. This abundant above, studies from our laboratory and others have dem-
onstrated a significant role for U3 sequences in stimulat-splicing factor can bind simultaneously to the U1 snRNA
and the SV40 pre-mRNA (Wassarman and Steitz, 1993; ing the 3* poly(A) site over the 5* poly(A) site (DeZazzo
et al., 1991, 1992; Brown et al., 1991; Valsamakis et al.,Lutz and Alwine, 1994). Alwine and colleagues have ex-
tended their analysis of SV40 pre-mRNA processing to 1991). In a recent report examining the mechanism of
this poly(A) site competition, it was suggested that U3show that the U1A protein directly contacts the 160-kDa
protein subunit of the polyadenylation factor CPSF (Lutz sequences function to strengthen the HIV-1 poly(A) site
in the event that it must compete with downstream pro-et al., 1996). These reports implicate U1A as the molecule
which coordinates the polyadenylation and splicing ma- cessing signals in the cellular genome and that U3 se-
quences are not necessary for polyadenylation nor dochineries to allow crosstalk to occur over the terminal
exon. Taken together, the data suggest a mechanism of they enhance polyadenylation when there is no nearby
competing site (Ashe et al., 1995). We propose that, incooperation between splicing and polyadenylation fac-
tors through U1A and CPSF to define the terminal exon addition to the demonstrated importance of U3 se-
quences for efficient polyadenylation, the positive effectof HIV-1.
At this point, it is important to note that although func- that splicing has on the U3-containing HIV-1 poly(A) site
is an extra layer of insurance that proviral transcripts willtional introns can stimulate polyadenylation and the sub-
sequent gene expression, several reports have demon- be polyadenylated properly, leading to appropriate gene
expression. Conversely, the reciprocal stimulation ofstrated that splicing sequences and factors can also
have negative influences on polyadenylation. The U1A splicing by polyadenylation ensures that HIV-1 tran-
scripts will become fully spliced during the early phaseprotein has been shown to downregulate its own expres-
sion by inhibiting polyadenylation of U1A pre-mRNA of the infection. This results in efficient expression of
mRNAs encoding transactivating and regulatory proteins,through a direct interaction with poly(A) polymerase
(Gunderson et al., 1994). It has also been shown that the such as Tat and Rev, which are needed in sufficient
quantity to regulate further mRNA biogenesis (Cullen,U1 snRNP can interfere with exon definition by binding
to a 5* splice site inserted within a 3* terminal exon (Niwa 1992). Later in the infection, Rev functions to regulate the
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